Adiponectin: An adipocyte-derived hormone, and its gene encoding in children with chronic kidney disease

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Elshamaa, Manal F ^a   Sabry, Samar M ^b   El Sonbaty, Marwa M ^a   Elghoroury, Eman A ^a   Emara, Nahed ^a   Raafat, Mona ^a   Kandil, Dina ^a   Elsaaid, Gamila ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Adiponectin; Children; CKD; Inflammation; Single nucleotide polymorphisms

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN;

ADIPOCYTE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; STATISTICAL MODEL;

ADIPOCYTES; ADIPONECTIN; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MUTATION;

EID: 84862239693     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-174     Document Type: Article

References (39)

1. Role of adiponectin in preventing vascular stenosis. M Matsuda, I Shimomura, M Sata, et al. J Biol Chem 2002 277 37487 37491 10.1074/jbc. M206083200 12138120
2. Novel modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. N Ouchi, S Kihara, Y Arita, et al. Circulation 1999 100 2473 2476 10.1161/01.CIR.100.25.2473 10604883 (Pubitemid 30005109)
3. Adiponectin, an adipocyte derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. N Ouchi, S Kihara, Y Arita, et al. Circulation 2000 102 1296 1301 10.1161/01.CIR.102.11.1296 10982546
4. Clinical epidemiology of cardiovascular disease in chronic renal failure. RN Foley, PS Parfrey, MJ Sarnak, Am J Kidney Dis 1998 32 Suppl 5 112 S119 9820470
5. Adipose tissueA novel endocrine organ of interest for the nephrologist. A Wiecek, F Kokot, J Chudek, M Adamczak, Nephrol Dial Transpl 2002 17 191 195 (Pubitemid 34157125)
6. Low fat adiponectin expression is associated with oxidative stress in non diabetic humans with chronic kidney diseaseimpact on plasma adiponectin concentration 1. B Rocco, B Annamaria, B Franco, S Annamaria, B Alessandra, M MariaPia, D Franca, Z Michela, G Gianfranco, Am J Physiol Regul Integr Comp Physiol 2007 293 47 R54 10.1152/ajpregu.00745.2006 17363678 (Pubitemid 47092161)
7. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. C Zoccali, F Mallamaci, G Tripepi, FA Benedetto, S Cutrupi, S Parlongo, LS Malatino, G Bonanno, G Seminara, F Rapisarda, P Fatuzzo, M Buemi, G Nicocia, S Tanaka, N Ouchi, S Kihara, T Funahashi, Y Matsuzawa, J Am Soc Nephrol 2002 13 134 141 11752030 (Pubitemid 34042020)
8. Adiponectin and mortality in patients with chronic kidney disease. V Menon, L Li, X Wang, T Greene, V Balakrishnan, M Madero, AA Pereira, GJ Beck, JW Kusek, AJ Collins, AS Levey, MJ Sarnak, J Am Soc Nephrol 2006 17 2599 2606 10.1681/ASN.2006040331 16885405 (Pubitemid 44300977)
9. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. B Becker, F Kronenberg, JT Kielstein, H Haller, C Morath, E Ritz, D Fliser, J Am Soc Nephrol 2005 16 1091 1098 10.1681/ASN.2004090742 15743998 (Pubitemid 41710320)
10. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. F Guebre-Egziabher, J Bernhard, T Funahashi, A Hadj-Aissa, D Fouque, Nephrol Dial Transplant 2005 20 129 134 10.1093/ndt/gfh568 15585515 (Pubitemid 40207617)
11. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. T Yamauchi, J Kamon, H Waki, et al. Nat Med 2001 7 887 888 10.1038/90911 11479613 (Pubitemid 32756414)
12. Reciprocal association of creative protein with adiponectin in blood stream and adipose tissue. N Ouchi, S Kihara, T Funahashi, et al. Circulation 2003 107 671 674 10.1161/01.CIR.0000055188.83694.B3 12578865 (Pubitemid 36222590)
13. Association between adiponectin and mediators of inflammation in obese women. S Engeli, M Feldpausch, K Gorzelniak, et al. Diabetes 2003 52 942 947 10.2337/diabetes.52.4.942 12663465 (Pubitemid 36384264)
14. The role of the novel adipocyte-derived hormone adiponectin in human disease. JJ Díez, P Iglesias, Eur J Clin Endocrin 2003 148 293 300 10.1530/eje.0.1480293 (Pubitemid 36410714)
15. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. AG Comuzzie, T Funahashi, G Sonnenberg, et al. J Clin Endocrinol Metab 2001 86 9 4321 4325 10.1210/jc.86.9.4321 11549668 (Pubitemid 32848553)
16. Genomic structure and mutations in adipose-specific gene, adiponectin. M Takahashi, Y Arita, K Yamagata, et al. Int J Obes 2000 24 7 861 868 10.1038/sj.ijo.0801244 (Pubitemid 30449921)
17. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. IM Heid, P Henneman, A Hicks, et al. Atherosclerosis 2010 208 2 412 420 10.1016/j.atherosclerosis.2009.11.035 20018283
18. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. K Hara, P Boutin, Y Mori, K Tobe, C Dina, K Yasuda, T Yamauchi, S Otabe, T Okada, K Eto, H Kadowaki, R Hagura, Y Akanuma, Y Yazaki, R Nagai, M Taniyama, K Matsubara, M Yoda, Y Nakano, M Tomita, S Kimura, C Ito, P Froguel, T Kadowaki, Diabetes 2002 51 536 540 11812766 (Pubitemid 34764814)
19. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. M Stumvoll, O Tschritter, A Fritsche, H Staiger, W Renn, M Weisser, F Machicao, H Haring, Diabetes 2002 51 37 41 10.2337/diabetes.51.2007.S37 11756320 (Pubitemid 34517977)
20. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. C Menzaghi, T Ercolino, R Di Paola, AH Berg, JH Warram, PE Scherer, V Trischitta, A Doria, Diabetes 2002 51 2306 2312 10.2337/diabetes.51.7.2306 12086965 (Pubitemid 34729040)
21. Young men with high normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. T Kazumi, A Kawaguchi, K Sakai, et al. Diabetes Care 2002 25 971 976 10.2337/diacare.25.6.971 12032101 (Pubitemid 41110480)
22. Decreased plasma adiponectin concentration in patients with essential hypertension. M Adamczak, A Wiecek, T Funahashi, et al. Am J Hypertens 2003 16 72 75 10.1016/S0895-7061(02)03197-7 12517687 (Pubitemid 36078595)
23. Association of hypoadiponectinemia with coronary artery disease in men. M Kumada, S Kihara, S Sumitsuji, et al. Arterioscler Thromb Vasc Biol 2003 23 85 89 10.1161/01.ATV.0000048856.22331.50 12524229 (Pubitemid 36091630)
24. Human genetics of adiponectin in the metabolic syndrome. W-S Yang, L-M Chuang, J Mol Med 2006 84 2 112 121 10.1007/s00109-005-0011-7 16389553 (Pubitemid 43201250)
25. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 Suppl 1 1 S266 11904577
26. Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? P Stenvinkel, P Barany, O Heimburger, R Pecoits-Filho, B Lindholm, Kidney Int 2002 61 Suppl 80 103 108
27. The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. DJ Sahn, A Demaria, J Kisslo, A Weyman, Circulation 1978 58 1072 1083 10.1161/01.CIR.58.6.1072 709763 (Pubitemid 9091990)
28. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. B Devereux, DR Alonso, EM Lutas, GJ Gottlieb, E Campo, I Sachs, N Reichek, Am J Cardiol 1986 57 450 458 10.1016/0002-9149(86)90771-X 2936235 (Pubitemid 16119719)
29. Function of CRP. TW Duclos, Ann Med 2000 32 274 278 10.3109/ 07853890009011772 10852144
30. Interleukin-6, anew target for therapy in multiple myloma? MH Van Oers, et al. Ann Hematology 1993 66 219 23 10.1007/BF01738469 (Pubitemid 23179043)
31. ACRP30, a new hormone controlling fat and glucose metabolism. TS Tsao, et al. Eur J Pharmacol 2002 440 2-3 213 221 12007537
32. Association of the human adiponectin gene and insulin resistance. E Filippi, F Sentinelli, V Trischitta, S Romeo, M Arca, F Leonetti, UD Mario, MG Baroni, Eur J Hum Genet 2004 12 199 205 10.1038/sj.ejhg.5201120 14673476 (Pubitemid 38499978)
33. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. JJ Diez, P Iglesias, MJ Fernandez-Reyes, A Aguilera, MA Bajo, P Alvarez-Fidalgo, R Codoceo, R Selgas, Clin Endocrinol 2005 62 242 249 10.1111/j.1365-2265.2005.02207.x (Pubitemid 40203922)
34. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease. N Tentolouris, D Doulgerakis, I Moyssakis, D Kyriaki, K Makrilakis, G Kosmadakis, D Stamatiadis, N Katsilambros, C Stathakis, Horm Metab Res 2004 36 721 727 10.1055/s-2004-826022 15523599 (Pubitemid 39486974)
35. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. K Hotta, T Funahashi, Y Arita, M Takahashi, M Matsuda, Y Okamoto, H Iwahashi, H Kuriyama, N Ouchi, K Maeda, M Nishida, S Kihara, N Sakai, T Nakajima, K Hasegawa, M Muraguchi, Y Ohmoto, T Nakamura, S Yamashita, T Hanafusa, Y Matsuzawa, Arterioscler Thromb Vasc Biol 2000 20 1595 1599 10.1161/01.ATV.20.6.1595 10845877 (Pubitemid 30353893)
36. Inflammation is associated with carotid atherosclerosis in dialysis patients. C Zoccali, FA Benedetto, F Mallamaci, G Tripepi, I Fermo, A Foca, R Paroni, LS Malatino, J Hypertens 2000 18 1207 1213 10.1097/00004872-200018090- 00006 10994751
37. Gu biomarkers of adiponectin: plasma protein variation and genomic DNA polymorphisms. F Harvest, Biomark Insights. 2009 4 123 133 20029651
38. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. WS Yang, PL Tsou, WJ Lee, et al. J Mol Med 2003 81 7 428 434 10.1007/s00109-002-0409-4 12750819 (Pubitemid 36900538)
39. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. TI Pollin, K Tanner, JR OConnell, et al. Diabetes 2005 54 1 268 274 10.2337/diabetes.54.1.268 15616038 (Pubitemid 40105122)